Hence, DNA damage-induced p53 activation plays critical roles in metabolic diseases, such as obesity and diabetes, suggesting that fine-tuning of the DNA damage response is essential for preventing and treating metabolic diseases [22]. This evidence concerns the gene TP53 and Other metabolic disease.